Optimal Anticoagulation During PCI - Sunil Rao, MD

preview_player
Показать описание
Presentation recorded at Cardiovascular Innovations 2017.

  1. Cardiovascular Innovations
  2. CVI2017
  3. Cardiovascular Cardiology
  4. Interventional Cardiology
  5. Cardiovascular Innovations
  6. Cardiovascular Innovations Foundation
Рекомендации по теме
Optimal Anticoagulation During 0:12:12

Optimal Anticoagulation During PCI - Sunil Rao, MD

Medicine Grand Rounds: 0:51:23

Medicine Grand Rounds: Antiplatelet and Anticoagulation Therapy After PCI 1/28/20

EHRA free webinar: 0:59:28

EHRA free webinar: New data in anticoagulation for patients with AF and PCI

Workshop 3 Anticoagulation 0:23:15

Workshop 3 Anticoagulation in a complex patient, e.g. CAD±PCI + AF

Anticoagulation in PCI 0:58:52

Anticoagulation in PCI - Karthik Murugiah - Oct 14 2020

How to optimise 0:45:50

How to optimise high-risk patient outcome? - EuroPCR 2023

ESC 23: RIGHT: 0:05:21

ESC 23: RIGHT: Post-PPCI Anticoagulation in STEMI Patients

Drugs and devices 0:58:26

Drugs and devices synergy: optimal DAPT & switching strategies - Round Table Webinar

Dual Versus Triple 0:06:59

Dual Versus Triple Therapy In Patients Undergoing Stent Implantation Who Are On Anticoagulation

ACS / Antithrombotics 0:21:57

ACS / Antithrombotics - S. Wassmann

How to manage 0:03:46

How to manage PCI in patients treated with oral anticoagulants – EuroPCR 2019

MASTER DAPT trial: 0:52:11

MASTER DAPT trial: Dual antiplatelet therapy after coronary stenting - AICT-AsiaPCR 2021

Cardiovascular Disease Management: 1:00:17

Cardiovascular Disease Management: Overcoming Access Barriers to Optimal Anticoagulation Treatment

THe New Era 0:58:14

THe New Era of Protected PCI webcast

Dual or Triple 0:19:47

Dual or Triple Therapy Post PCI - Dr. Usman Baber

Bivalirudin vs. Heparin 0:07:01

Bivalirudin vs. Heparin in STEMI, NSTEMI Patients Undergoing PCI

Genotype Directed Antiplatelet 0:47:23

Genotype Directed Antiplatelet Therapy, Is the Time Right?

Boston Scientific Symposia: 0:59:56

Boston Scientific Symposia: Next Frontier in Complex Coronary Artery Disease Management

Round Table Webinar 0:58:22

Round Table Webinar - The SYNTAX II strategy: integrating best practices in complex PCI

Managing Triple Therapy 0:58:49

Managing Triple Therapy in ACS

Management of Atrial 0:58:49

Management of Atrial Fibrillation (AF) with ACS and/or Undergoing PCI

Controversy: Dual vs 0:54:24

Controversy: Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best?

Anticoagulation, Hemostasis, and 0:54:07

Anticoagulation, Hemostasis, and Reversal in Neurosurgery by Dr. Christopher Loftus

Complex PCI in 0:57:15

Complex PCI in high-bleeding risk patients - A case-based approach